Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses
Abstract Xenotransplantation (cross-species transplantation) using genetically-engineered pig organs offers a potential solution to address persistent organ shortage. Current evaluation of porcine genetic modifications is to monitor the nonhuman primate immune response and survival after pig organ x...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3ae22fee438c45fa9103891970992214 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3ae22fee438c45fa9103891970992214 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3ae22fee438c45fa91038919709922142021-12-02T18:02:53ZGenetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses10.1038/s41598-021-92543-y2045-2322https://doaj.org/article/3ae22fee438c45fa91038919709922142021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-92543-yhttps://doaj.org/toc/2045-2322Abstract Xenotransplantation (cross-species transplantation) using genetically-engineered pig organs offers a potential solution to address persistent organ shortage. Current evaluation of porcine genetic modifications is to monitor the nonhuman primate immune response and survival after pig organ xenotransplantation. This measure is an essential step before clinical xenotransplantation trials, but it is time-consuming, costly, and inefficient with many variables. We developed an efficient approach to quickly examine human-to-pig xeno-immune responses in vitro. A porcine endothelial cell was characterized and immortalized for genetic modification. Five genes including GGTA1, CMAH, β4galNT2, SLA-I α chain, and β2-microglobulin that are responsible for the production of major xenoantigens (αGal, Neu5Gc, Sda, and SLA-I) were sequentially disrupted in immortalized porcine endothelial cells using CRISPR/Cas9 technology. The elimination of αGal, Neu5Gc, Sda, and SLA-I dramatically reduced the antigenicity of the porcine cells, though the cells still retained their ability to provoke human natural killer cell activation. In summary, evaluation of human immune responses to genetically modified porcine cells in vitro provides an efficient method to identify ideal combinations of genetic modifications for improving pig-to-human compatibility, which should accelerate the application of xenotransplantation to humans.Ping LiJulia R. WalshKevin LopezAbdulkadir IsidanWenjun ZhangAngela M. ChenWilliam C. GogginsNancy G. HigginsJianyun LiuRandy R. BrutkiewiczLester J. SmithHidetaka HaraDavid K. C. CooperBurcin EkserNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Ping Li Julia R. Walsh Kevin Lopez Abdulkadir Isidan Wenjun Zhang Angela M. Chen William C. Goggins Nancy G. Higgins Jianyun Liu Randy R. Brutkiewicz Lester J. Smith Hidetaka Hara David K. C. Cooper Burcin Ekser Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses |
description |
Abstract Xenotransplantation (cross-species transplantation) using genetically-engineered pig organs offers a potential solution to address persistent organ shortage. Current evaluation of porcine genetic modifications is to monitor the nonhuman primate immune response and survival after pig organ xenotransplantation. This measure is an essential step before clinical xenotransplantation trials, but it is time-consuming, costly, and inefficient with many variables. We developed an efficient approach to quickly examine human-to-pig xeno-immune responses in vitro. A porcine endothelial cell was characterized and immortalized for genetic modification. Five genes including GGTA1, CMAH, β4galNT2, SLA-I α chain, and β2-microglobulin that are responsible for the production of major xenoantigens (αGal, Neu5Gc, Sda, and SLA-I) were sequentially disrupted in immortalized porcine endothelial cells using CRISPR/Cas9 technology. The elimination of αGal, Neu5Gc, Sda, and SLA-I dramatically reduced the antigenicity of the porcine cells, though the cells still retained their ability to provoke human natural killer cell activation. In summary, evaluation of human immune responses to genetically modified porcine cells in vitro provides an efficient method to identify ideal combinations of genetic modifications for improving pig-to-human compatibility, which should accelerate the application of xenotransplantation to humans. |
format |
article |
author |
Ping Li Julia R. Walsh Kevin Lopez Abdulkadir Isidan Wenjun Zhang Angela M. Chen William C. Goggins Nancy G. Higgins Jianyun Liu Randy R. Brutkiewicz Lester J. Smith Hidetaka Hara David K. C. Cooper Burcin Ekser |
author_facet |
Ping Li Julia R. Walsh Kevin Lopez Abdulkadir Isidan Wenjun Zhang Angela M. Chen William C. Goggins Nancy G. Higgins Jianyun Liu Randy R. Brutkiewicz Lester J. Smith Hidetaka Hara David K. C. Cooper Burcin Ekser |
author_sort |
Ping Li |
title |
Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses |
title_short |
Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses |
title_full |
Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses |
title_fullStr |
Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses |
title_full_unstemmed |
Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses |
title_sort |
genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/3ae22fee438c45fa9103891970992214 |
work_keys_str_mv |
AT pingli geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses AT juliarwalsh geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses AT kevinlopez geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses AT abdulkadirisidan geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses AT wenjunzhang geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses AT angelamchen geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses AT williamcgoggins geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses AT nancyghiggins geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses AT jianyunliu geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses AT randyrbrutkiewicz geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses AT lesterjsmith geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses AT hidetakahara geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses AT davidkccooper geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses AT burcinekser geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses |
_version_ |
1718378860817416192 |